13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-08-14 Event 2026-08-12 SEC 0001072613-26-000686 →

SR ONE CAPITAL MANAGEMENT, LLC Veradermics, Inc. MANE

Stake: Shares: 2,080,119 Class: Common Stock, $0.00001 par value per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
1 13D/G filings on this issuer
0 other filings besides this one
Filer Track Record
6 filings by this filer
5 other filings in the data moat
Short Interest · settle 2026-07-31
DTC 6.92
4,820,395 shares short · +22.5% vs prior

Institutional Consensus · 2026-06-30

Held by elite portfolio managers
1 holder · $191.97M
Viking Global

Other Filings by SR ONE CAPITAL MANAGEMENT, LLC

FiledFormIssuerStakeShares
2026-05-18 SCHEDULE 13D Odyssey Therapeutics, Inc. ODTX 8.00% 3,794,883 view →
2025-10-01 SCHEDULE KALA BIO, Inc. KALA 5.50% 411,000 view →
2023-12-18 SC Arcellx, Inc. ACLX view →
2023-06-02 SC Arcellx, Inc. ACLX view →
2022-06-27 SC Arcellx, Inc. ACLX view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →